novartis

novartis announced a breakthrough in its oncology pipeline this quarter.

the novartis ceo outlined plans to expand into emerging markets.

novartis reported a 12% rise in annual revenue, exceeding analyst expectations.

a new partnership between novartis and a biotech firm aims to accelerate drug discovery.

novartis headquarters in basel is undergoing a major renovation to enhance collaboration.

the novartis acquisition of the startup strengthens its rare disease portfolio.

investors reacted positively to novartis's increased dividend payout.

novartis launched a new patient assistance program for its costly immunotherapy.

the novartis clinical trial for the novel alzheimer's drug showed promising results.

novartis share price rose sharply after the fda approved its flagship therapy.

novartis has invested heavily in digital health technologies to improve patient outcomes.

the novartis board approved a share buyback program worth $5 billion.